 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) was the target of a significant
  increase in short interest in the month of December. As of December 31st, there
  was short interest totalling 267,800 shares, an increase of 71.7% from the December
  15th total of 156,000 shares. Based on an average ...


Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) Short Interest Up 71.7% in December

---
- 'PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight
  management aid, has completed its business combination with Capstar Special Purpose
  Acquisition Corp (NYSE: CPSR). The publicly-traded company will be Gelesis Holdings
  Inc and will begin trading on the New York Stock Exchange under the ticker symbol
  "GLS" from today.'


Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today

---
- 'Gelesis, the maker of Plenity, an FDA-cleared weight management approach, announced
  today the completion of its business combination with Capstar Special Purpose Acquisition
  Corp. (NYSE: CPSR) (Capstar). The publicly traded company will be known as Gelesis
  Holdings, Inc. (Gelesis or the Company...'


Gelesis, the Maker of Plenity for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

---
- Gelesis, a biotherapeutics company focused on excess weight and metabolic disorders
  and the maker of Plenity, announced the appointment of senior financial executive
  Ali Bauerlein to its Board of Directors. Ms. Bauerlein brings extensive experience
  in SEC reporting, Sarbanes-Oxley compliance...


Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

---
- Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) was the recipient of a large
  decrease in short interest during the month of November. As of November 30th, there
  was short interest totalling 156,900 shares, a decrease of 24.6% from the November
  15th total of 208,000 shares. Based on an average ...


Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) Short Interest Down 24.6% in November

---
- Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) was the recipient of a significant
  decline in short interest in November. As of November 30th, there was short interest
  totalling 156,900 shares, a decline of 24.6% from the November 15th total of 208,000
  shares. Currently, 0.6% of the companys ...


Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) Sees Significant Decrease in Short Interest

---
- Gelesis, the maker of Plenity, an FDA-cleared weight management approach, has created
  an edible billboard in New York Citys Astor Place to challenge the idea that people
  cant eat the foods they love while losing weight. This press release features multimedia.
  View the full release here...


Have Your Cake and Eat It Too: Plenity Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions

---
- Bank of America Corp DE raised its position in Capstar Special Purpose Acquisition
  Corp. (NYSE:CPSR) by 9.5% during the second quarter, Holdings Channel reports. The
  firm owned 155,337 shares of the companys stock after buying an additional 13,490
  shares during the quarter. Bank of America Corp DEs ...


Capstar Special Purpose Acquisition Corp. (NYSE:CPSR) Shares Purchased by Bank of America Corp DE

---
- Seelaus Asset Management LLC lowered its stake in shares of Capstar Special Purpose
  Acquisition Corp. (NYSE:CPSR) by 7.9% during the third quarter, Holdings Channel
  reports. The fund owned 42,170 shares of the companys stock after selling 3,600
  shares during the period. Seelaus Asset Management LLCs...


Seelaus Asset Management LLC Has $418,000 Stock Holdings in Capstar Special Purpose Acquisition Corp. (NYSE:CPSR)

---
- Gelesis, a consumer-focused biotherapeutics company, is proud to announce Plenity,
  an FDA cleared weight management approach, is now broadly available across the United
  States to adults who meet the prescription criteria. The company is also pleased
  to announce the appointment of leading health and...


Gelesis FDA-Cleared Weight Management Approach, Plenity, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

Gelesis Holdings, Inc. operates as a biotechnology company. The firm engages in developing a novel category of therapies for weight management and gut related chronic diseases. The company was founded on February 15, 2006 and is headquartered in Boston, MA.

Watchers	120
52-Wk Low	$0.0003
52-Wk High	$0.54

Market Cap	$110,003.00
Volume (M)	1,334.00
52-Wk High	$0.54
52-Wk Low	$0.0003

CPSR Capstar Special Purpose Acquisition Corp - Ordinary Shares - Class A

About

Feed

News

Fundamentals